Cas no 132294-76-9 (Sachaliside)
Sachaliside Chemical and Physical Properties
Names and Identifiers
-
- 4-hydroxycinnamyl alcohol 9-O-beta-D-glucopyranoside
- 4-hydroxycinnamyl O-beta-D-glucopyranoside
- p-coumaryl alcohol-gamma-O-beta-D-glucopyranoside
- sachaliside
- sachaliside 1
- triandirin
- triandrin
- 19764-35-3
- beta-D-Glucopyranoside, (2E)-3-(4-hydroxyphenyl)-2-propen-1-yl
- .BETA.-D-GLUCOPYRANOSIDE, (2E)-3-(4-HYDROXYPHENYL)-2-PROPEN-1-YL
- AKOS040753896
- MEGxp0_001501
- AKOS040763037
- CHEBI:181987
- Sachaliside, (-)-
- NCGC00385488-01_C15H20O7_beta-D-Glucopyranoside, (2E)-3-(4-hydroxyphenyl)-2-propen-1-yl
- .BETA.-D-GLUCOPYRANOSIDE, 3-(4-HYDROXYPHENYL)-2-PROPENYL, (E)-
- Q27268953
- (E)-Triandrin
- beta-D-Glucopyranoside, 3-(4-hydroxyphenyl)-2-propenyl, (E)-
- beta-D-Glucopyranoside, 3-(4-hydroxyphenyl)-2-propen-1-yl
- UNII-7WNF6LR591
- (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(E)-3-(4-hydroxyphenyl)prop-2-enoxy]oxane-3,4,5-triol
- 7WNF6LR591
- 132294-76-9
- NCGC00385488-01
- (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(((E)-3-(4-hydroxyphenyl)allyl)oxy)tetrahydro-2H-pyran-3,4,5-triol
- CHEMBL3581238
- HY-123286
- Sachaliside
-
- Inchi: 1S/C15H20O7/c16-8-11-12(18)13(19)14(20)15(22-11)21-7-1-2-9-3-5-10(17)6-4-9/h1-6,11-20H,7-8H2/b2-1+/t11-,12-,13+,14-,15-/m1/s1
- InChI Key: CNNXMGXBAZQZDE-HHMSBIESSA-N
- SMILES: O1[C@H]([C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O)OC/C=C/C1C=CC(=CC=1)O
Computed Properties
- Exact Mass: 312.12090297g/mol
- Monoisotopic Mass: 312.12090297g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 22
- Rotatable Bond Count: 5
- Complexity: 354
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 5
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.4
- Topological Polar Surface Area: 120?2
Sachaliside Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | S080790-1mg |
Sachaliside |
132294-76-9 | 1mg |
$207.00 | 2023-05-17 | ||
| TRC | S080790-5mg |
Sachaliside |
132294-76-9 | 5mg |
$953.00 | 2023-05-17 | ||
| TRC | S080790-10mg |
Sachaliside |
132294-76-9 | 10mg |
$1642.00 | 2023-05-17 | ||
| TRC | S080790-100mg |
Sachaliside |
132294-76-9 | 100mg |
$ 9200.00 | 2023-09-06 |
Sachaliside Related Literature
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
Related Categories
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acyl glycosides of mono- and disaccharides
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acyl glycosides Fatty acyl glycosides of mono- and disaccharides
Additional information on Sachaliside
Comprehensive Overview of Sachaliside (CAS No. 132294-76-9): Properties, Applications, and Research Insights
Sachaliside (CAS No. 132294-76-9) is a naturally occurring bioactive compound that has garnered significant attention in recent years due to its potential therapeutic properties. This glycoside derivative is primarily found in select plant species and has been studied for its unique pharmacological effects. Researchers have identified Sachaliside as a promising candidate for various health-related applications, particularly in the fields of nutraceuticals and complementary medicine.
The molecular structure of Sachaliside features a distinctive sugar moiety attached to an aglycone component, which contributes to its biological activity. With a molecular weight of approximately 534.5 g/mol, this compound exhibits moderate solubility in polar solvents, making it suitable for various formulation approaches. The Sachaliside molecular structure has been extensively characterized using advanced techniques such as NMR spectroscopy and mass spectrometry, confirming its purity and stability under standard conditions.
Current research trends highlight growing interest in Sachaliside health benefits, with particular focus on its antioxidant and anti-inflammatory properties. These characteristics align with the increasing consumer demand for natural compounds that support cellular health and longevity. Studies suggest that Sachaliside may modulate key signaling pathways involved in oxidative stress response, positioning it as a potential ingredient in functional foods and dietary supplements.
From a commercial perspective, Sachaliside extraction methods have become a topic of significant innovation. Modern techniques employing green chemistry principles and sustainable sourcing practices are being developed to improve yield while minimizing environmental impact. The optimization of Sachaliside production processes has enabled more consistent quality and availability for research and development purposes.
The safety profile of Sachaliside has been evaluated in preliminary toxicological studies, showing favorable results at physiological concentrations. However, comprehensive clinical trials are still needed to fully establish its safety and efficacy parameters. This cautious approach reflects the pharmaceutical industry's commitment to evidence-based development of natural compounds.
In the context of intellectual property, several patents related to Sachaliside applications have been filed in recent years, covering various formulations and delivery systems. These innovations demonstrate the compound's versatility and potential for commercialization in different product categories, from cosmeceuticals to specialized nutritional products.
Analytical methods for Sachaliside quantification have been refined to support quality control in manufacturing processes. High-performance liquid chromatography (HPLC) coupled with advanced detection systems now allows for precise measurement of Sachaliside content in complex matrices, ensuring product consistency and regulatory compliance.
The market potential for Sachaliside-containing products continues to grow, driven by consumer interest in plant-based bioactive compounds. Market analysts project steady growth in this sector, particularly in regions with strong demand for natural health products. This trend aligns with broader shifts toward preventive healthcare and personalized nutrition solutions.
From a research perspective, ongoing investigations into Sachaliside mechanism of action are uncovering novel biological targets and potential therapeutic applications. Cutting-edge omics technologies are being employed to elucidate the compound's effects at the molecular level, providing insights that may guide future product development.
Quality standards for Sachaliside raw material have been established by several industry organizations, addressing parameters such as purity, residual solvents, and heavy metal content. These standards help ensure the reliability and safety of Sachaliside as it moves through the supply chain from raw material to finished product.
In formulation science, challenges related to Sachaliside bioavailability have prompted innovative approaches to enhance its absorption and stability. Advanced delivery systems, including lipid-based carriers and nanotechnology applications, are being explored to maximize the compound's therapeutic potential.
The regulatory landscape for Sachaliside varies by jurisdiction, with some regions classifying it as a novel food ingredient requiring pre-market approval. Manufacturers and distributors must navigate these regulations carefully to ensure compliance while bringing Sachaliside products to market.
Future research directions for Sachaliside may include exploration of synergistic effects with other bioactive compounds, development of standardized extraction protocols, and investigation of potential applications in specialized health areas. The compound's versatility suggests numerous opportunities for innovation in both research and commercial applications.
As interest in Sachaliside continues to grow, collaboration between academic researchers, industry professionals, and regulatory bodies will be essential to fully realize its potential. The compound represents an exciting example of how natural products can contribute to advancing health and wellness solutions in scientifically validated ways.
132294-76-9 (Sachaliside) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)